Document is current
Any future updates will be listed below
-
Authors
Kühne, Felicitas https://orcid.org/0000-0001-9762-3842
von Eiff, Christof
Schiffner-Rohe, Julia
Döring, Lina
Gerchow, Kathrin https://orcid.org/0000-0003-2769-0075
Seidel, Karolin https://orcid.org/0000-0002-2682-5620
Laurenz, Maren
-
Funding
Funding for this research was provided by:
Pfizer Pharma GmbH
- License Information
-
More Information
Article History
Received: 7 October 2024
Accepted: 30 May 2025
First Online: 17 July 2025
Declarations
:
: F. Kühne, C. von Eiff, J. Schiffner-Rohe, L. Döring, and M. Laurenz are employees of Pfizer Pharma GmbH and may hold stocks or stock options. K. Gerchowand K. Seidel are employed by Xcenda GmbH, part of Cencora, which received consulting fees for the execution of the study and preparation of the manuscript from Pfizer Pharma GmbH, Germany.
: This study did not require review of an ethics committee or institutional review board as the data was not identifiable. It used anonymized German claims data from the “Institut für angewandte Gesundheitsforschung Berlin” (InGef) database. According to the guideline GPS – Good Practice in Secondary Data Analysis, no consultation of an ethics committee is required for secondary data analyses.
